BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 25460302)

  • 1. Targeting cancer stem cells in solid tumors by vitamin D.
    So JY; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():79-85. PubMed ID: 25460302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery approaches to target Wnt signaling in cancer stem cells.
    Curtin JC; Lorenzi MV
    Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental signaling pathways in cancer stem cells of solid tumors.
    Karamboulas C; Ailles L
    Biochim Biophys Acta; 2013 Feb; 1830(2):2481-95. PubMed ID: 23196196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma.
    Pang RW; Poon RT
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1081-94. PubMed ID: 22873219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment.
    Islam F; Gopalan V; Smith RA; Lam AK
    Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer stem cells and implications for future therapeutics.
    Wang J; Li ZH; White J; Zhang LB
    Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer stem cells by curcumin and clinical applications.
    Li Y; Zhang T
    Cancer Lett; 2014 May; 346(2):197-205. PubMed ID: 24463298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in Lung Stem Cells and Lung Cancer Stem Cells].
    Yin H; Deng J
    Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):633-9. PubMed ID: 26483336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.